Objective: Advances in stent technology have enabled the delivery of drugs to improve outcomes after stent deployment. However, the optimal payloads for stents are not clear, and the appropriate stent-based therapies for high-risk patients, such as diabetics, have not been clearly established.
Methods And Results: We used smooth muscle cell culture models to compare the activities of rapamycin and paclitaxel.